Rare Diseases, Unique Solutions: Insights from Pharma Leaders

If you registered for the live event at the time, then please use the same link and access code to rewatch a recording of the live event video stream!


Feb 27 2024


7:45 am - 9:00 am

Join our panel discussion!


  • Gain insights into the role of pharmaceutical companies in addressing rare diseases, from drug development to commercialization.

  • Understand the current landscape of rare diseases, including federal policy, patient advocacy groups, challenges in diagnosis, and unmet needs.

  • Understand the unique challenges and opportunities in commercializing pharmaceutical products for rare diseases, including sustainability, market sizing, and targeting strategies.

  • Explore effective sales strategies and tactics for engaging healthcare providers and other stakeholders in the rare disease space.

At the end of the panel discussion, our speakers answer questions received via chat during the event.


  • Anand Janack
    Anand Janack
    Vice President and General Manager, BioCryst Pharmaceuticals Inc.

    A people-first, customer-focused, results-oriented healthcare executive with over 20 years of experience spanning multiple areas; these include public health threat therapeutics, rare diseases, biotech and medical devices. Bilingual fluency (French and English) adds a further dimension. Innovative, decisive, and a strong communicator effective in achieving team consensus, and business objectives. As a registered Pharmacist, sees the issues as a healthcare provider but above all, looks for the opportunities through the eyes of a driven, and passionate solution-seeker and team coach.

  • Margaret Gunarsons
    Margaret Gunarsons
    Commercial Lead, Rare Disease, Takeda

    Building and realizing an ambitious vision with a diverse team to serve patients drives my purpose every day.

    As a pharmaceutical commercial leader, I have delivered on business goals for more than 25 years. My experience leading cross-functional, marketing and sales teams spans across the complete lifecycle of brands including pipeline, launch, growth and post patent. My career has taken me from the high share of voice needed for primary care brands, the scientific and technical skills required for success in specialty care and biotech and now to the strong patient focus in the rare disease space.

    I love to connect with people across the globe with the goal of understanding their world and learning from their unique perspectives and talents. International travel to meet and collaborate with colleagues is one of the many things that I miss most during this time of COVID-19 lockdowns.

    My personal wish for patients is that they can get a quicker diagnosis of their conditions and that there are therapies available that they can access. In the end, all patients have the right to live their lives to their fullest potential. Through empathy and determination, I have developed strong bonds with patient groups and physicians who dedicate themselves to the patients who need their compassion and expertise.

    I thrive on sharing my vision through engaging presentations and workshops and getting the team around me to feel the same passion. I’m a life-long learner and embarked on an MBA program a few years ago and earned my degree in 2018.

  • Morgan McNaughton
    Morgan McNaughton
    Patient Experience Lead, Neurology & Rare Disease, UCB

    Experienced leader with a demonstrated history of working in the pharmaceutical industry in both specialty care and rare disease. Skilled in Management, Business Strategy, Pharmaceutical Sales & Marketing, and Patient Value & Access. MBA from Schulich School of Business – York University, with specialization in Brand Management and Strategic Management.

  • Sandra Taza
    Sandra Taza
    Key Account Manager, Rare Disease, Amicus Therapeutics

Join our Mailing list!

Get all latest news about our programs, subscribe to our newsletter!